The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Expect volatility, but if Chinese pharmaceutical usage begins to rise from its current very low level (compared to western countries), this company will reap huge benefits. With the growth of Chinese economy, rapid increase in disposable income and the desire to adopt western ways, this could be a rocket (or a dud, if the naysayers are correct). Not for the faint of heart, but a worthwhile gamble here in CAPS.